https://www.selleckchem.com/pr....oducts/eeyarestatin-
inflammatory markers and hepatobiliary enzymes. The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is an ongoing debate and novel data has emerged. The aim of this meta-analysis was to assess outcomes of short vs. control DAPT duration. In addition, the role of single antiplatelet therapy (SAPT) after DAPT with either aspirin or P2Y monotherapy was analyzed. The authors searched MEDLINE and Cochrane databases and proceedings of international meetings for randomized controlled tria
Beğen
Yorum Yap
Paylaş
